All Type of News
3Q national health insurance in the black
The National Health Insurance Corp. (NHIC) said Thursday that the national health insurance fund was 487.3 billion won in the black during the third quarter of the year.
The corporation’s total income from January ...
SK to launch Mvix-S 100 mg as DTF
SK Chemicals said it will launch a dissolvable oral thin film (DTF) of Mvix-S 100 mg from Dec. 13, following Mvix-S 50 mg in December of last year.
The company said the insurance price of Mvix-S 100 mg is set at 7,...
Hanmi teams up with Kainos
Hanmi Pharm said Wednesday it has signed a research and licensing partnership agreement with Kainos Medicine Inc., a local biopharmaceutical firm, to push ahead with the global new drug discovery project.
According...
M&As in domestic pharmaceutical sector will go up
Pharmaceutical companies could benefit from mergers and acquisitions (M&As) in the changing business environment of the 21st century, according to a research institute said Wednesday.
In a conference hosted by Kore...
Korea drug makers see their cash reserves shrinking
Domestic drug companies’ cash reserves their cash reserves drop slightly, but their liquidity conditions beyond the industry’s average raise no concerns, according to the data by Yakup.com.
According to the report,...
Handok is still in negation with Teva
Handok Pharm said it is still proceeding with preliminary negotiations with Teva Pharmaceutical Industries Ltd., the world’s largest generic manufacturer.
In a regulatory filing on Tuesday, Handok said that the pos...
Pharmaceutical firms advised to go global
Korean pharmaceutical companies, which traditionally have depended on the local market, need to turn their eyes on the overseas market, said Kim Won-bae, president of Dong-A Pharm.
In a local seminar organized by t...
Kim Jin-ho tapped as senior vice president in North AsiaKim Jin-ho, CEO of GSK Korea, has been recently promoted to senior vice president within GSK Group.
In line with GSK’s global reshuffling, Kim will be responsible for taking ...
|
Korean drug makers boosting R&D spending
Local drug makers have been spending more on research and development (R&D) projects to strengthen their technology leadership as 43 pharmaceutical firms were called innovative drug firm in June by the government and ...
What is Teva’s real intention in Korean market?
There are possibilities that the world’s largest generic manufacturer, Israel-based Teva, could acquire a local firm, according to the financial industry.
Handok Pharm was considered one possible target among inve...
